{"title":"J&J COVID vaccine use paused due to one-in-a-million complication","link":"https://arstechnica.com/?p=1756531","date":1618319260000,"content":"<div>\n<figure><img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232272167-800x534.jpg\" /><p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232272167.jpg\">Enlarge</a> <span>/</span> A nurse practitioner named Heidi Johnson administers a vaccine from Johnson &amp; Johnson. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/rishell-of-cleveland-park-receives-the-johnson-johnson-news-photo/1232272167?adppopup=true\">Tom Williams / Getty Images</a>)</p>  </figure><div><a name=\"page-1\"></a></div>\n<p>On Tuesday morning, the US Food and Drug Administration and the Centers for Disease Control and Prevention issued a release acknowledging an extremely rare clotting disorder was associated with the use of the Johnson &amp; Johnson COVID vaccine. The problem is actually less than a one-in-a-million issue; in data from the US, where 6.8 million doses of this vaccine have been used, there have only been six instances of the clotting problem detected.</p>\n<p>Because the clots call for an unusual treatment, however, the organizations are calling for a pause in administering the shot. This will provide them with time to ensure the medical community is aware of the appropriate treatment.</p>\n<p>This is not the first vaccine to create extremely rare clotting issues. They've also been seen following <a href=\"https://arstechnica.com/science/2021/04/blood-clots-are-very-rare-side-effects-of-astrazeneca-vaccine-eu-regulators/\">use of the AstraZeneca vaccine</a>. The problem appears to be caused by the harmless virus (an Adenovirus) that carries a single gene from SARS-CoV-2 in order to elicit an immune response.</p></div><p><a href=\"https://arstechnica.com/?p=1756531#p3\">Read 7 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1756531&amp;comments=1\">Comments</a></p>","author":"John Timmer","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"231e0ad3267fbeeaf604adf4ce899e824839f7dbaccbcd4be8df34669cf1614c","category":"Tech"}